A glance at what’s happening in the world of technology - Winter 2023.
Gene therapy for Stargardt disease in the offing
Scientists at the National Eye Institute have found the first direct evidence that Stargardt-related ABCA4 gene mutations affect the retinal pigment epithelium (RPE).
The discovery points to a new understanding of the progression of this rare inherited blinding disease and suggests a therapeutic strategy. The research team used a new stem cell-based model made from skin cells, according to the study published in Stem Cell Reports.
Sign in to continue
Not already a member of the College?
Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
The College and Eye Research Group Oxford are collaborating to bring you a webinar on Monday 24 June, on how optometrists can get involved in research.
As the schools break up for the summer holidays, and many look forward to spending more time outside in the sunshine, the College has issued tips to support the public in protecting their eyes from the sun.